Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural Analgesia and NK Cell Activity in Colonic Cancer Surgery
NCT02326727Unknown
- Sponsor
- Hillel Yaffe Medical Center
- Start
- Apr 2015
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of ropivacaine in colon cancer (2 arms), sponsored by Hillel Yaffe Medical Center. Primary endpoints: Count of live and dead target erythroleukemic cells at 72 hours and Plasma concentration of cytokines at 72 hours. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT02326727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02326727.